MONTREAL, Nov. 24, 2014 /CNW Telbec/ - On November 25, the Neomed Institute will host Pharmed Finance 2014, an event that will bring together hundreds of investors and life science industry leaders.
"Pharmed Finance is a forum that will showcase business opportunities and new financing models in the field of biopharmaceuticals, as well as in mobile health applications. Life science financing is doing relatively well, in particular with a marked increase in American venture capital which achieved success in 2013 and 2014. This forum will discuss new models of financing, including crowdfunding," explains Perry Niro, Director of the ETS Centech Fund and Chair of PHARMED Québec, which is organizing the event.
Our speakers will include Peter Brenders, General Manager of Genzyme, Loyd Seagal, a partner at Persistence Capital Partners, Nicola Urbani, Vice-President, Commercialization at the Jewish General Hospital of Montreal, Charles Deguire, Co-founder and CEO of Kinova Robotics, Code Cubitt, partner at Mistral Venture Partners, and Cynthia Lavoie, partner at TVM Capital Life Science.
The return of Jonathan Goodman
The keynote speaker of the event is Jonathan Goodman, founder of Paladin and now President of Knight Therapeutic, a new biopharmaceutical firm; he is also a partner in the new Teralys Capital innovation fund. Mr. Goodman will share the inside story of the transaction that resulted in the sale of Paladin for $1.3 billion in 2013.
This unique conference is an initiative of Pharmed Québec, the network of health industry manufacturers and suppliers.
For further information: Perry Niro, PHARMED FINANCE 2014, (438) 814-2167, [email protected], www.pharmedfinance.com, www.pharmedcanada.ca